✦ LIBER ✦

Activation of Ras/MAPK and mTOR pathways in hepatocellular carcinoma: Tumor growth inhibition with Ras/mTOR pathway abrogation by a novel combination of Sorafenib and rapamycin

✍ Scribed by Philippa H. Newell; Augusto Villanueva; Judit Peix; Isabel Fiel; Swan Thung; Steven Yea; Sasan Roayaie; Myron Schwartz; Scott Friedman; Josep Llovet

Book ID: 113678119
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 55 KB
Volume: 205
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2007.06.234

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ras pathway activation in hepatocellular

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

✍ Pippa Newell; Sara Toffanin; Augusto Villanueva; Derek Y. Chiang; Beatriz Mingue 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 531 KB

155. Tumor Necrosis In Vivo Caused by a

155. Tumor Necrosis In Vivo Caused by a Novel Combination of Sorafenib and Rapamycin: Targeting the RAS and Motor Pathways ION Hepatocellular Carcinoma

✍ Pippa H. Newell; Augusto Villanueva; Judit Peix; Stijn van Laarhoven; Isabel Fie 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 148 KB